FEIA was adopted for the first time in the present preliminary study to evaluate KL-6 concentrations in serum samples from COVID-19 hospitalized patients including a cohort of patients followed after hospital discharge in order to assess the comparison between two methods: CLEIA and FEIA. Here, MUC1 is linked to COVID-19.